AAAAAA

   
Results: 1-11 |
Results: 11

Authors: McDonnell, SK Schaid, DJ Myers, JL Grant, CS Donohue, JH Woods, JE Frost, MH Johnson, JL Sitta, DL Slezak, JM Crotty, TB Jenkins, RB Sellers, TA Hartmann, LC
Citation: Sk. Mcdonnell et al., Efficacy of contralateral prophylactic mastectomy in women with a personaland family history of breast cancer, J CL ONCOL, 19(19), 2001, pp. 3938-3943

Authors: Roberts, WW Bergstralh, EJ Blute, ML Slezak, JM Carducci, M Han, M Epstein, JI Eisenberger, MA Walsh, PC Partin, AW
Citation: Ww. Roberts et al., Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy, UROLOGY, 57(6), 2001, pp. 1033-1037

Authors: Roberts, SG Blute, ML Bergstralh, EJ Slezak, JM Zincke, H
Citation: Sg. Roberts et al., PSA doubling time as a predictor of clinical progression after biochemicalfailure following radical prostatectomy for prostate cancer, MAYO CLIN P, 76(6), 2001, pp. 576-581

Authors: Amling, CL Bergstralh, EJ Blute, ML Slezak, JM Zincke, H
Citation: Cl. Amling et al., Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?, J UROL, 165(4), 2001, pp. 1146-1151

Authors: Frost, MH Schaid, DJ Sellers, TA Slezak, JM Arnold, PG Woods, JE Petty, PM Johnson, JL Sitta, DL McDonnell, SK Rummans, TA Jenkins, RB Sloan, JA Hartmann, LC
Citation: Mh. Frost et al., Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy, J AM MED A, 284(3), 2000, pp. 319-324

Authors: Blute, ML Bergstralh, EJ Partin, AW Walsh, PC Kattan, MW Scardino, PT Montie, JE Pearson, JD Slezak, JM Zincke, H
Citation: Ml. Blute et al., Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer, J UROL, 164(5), 2000, pp. 1591-1595

Authors: Sato, K Qian, JQ Slezak, JM Lieber, MM Bostwick, DG Bergstralh, EJ Jenkins, RB
Citation: K. Sato et al., Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma, J NAT CANC, 91(18), 1999, pp. 1574-1580

Authors: Brown, MJA Slezak, JM Lieber, MM Jenkins, RB
Citation: Mja. Brown et al., Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radicalprostatectomy, MAYO CLIN P, 74(12), 1999, pp. 1214-1220

Authors: Sweat, SD Pacelli, A Bergstralh, EJ Slezak, JM Bostwick, DG
Citation: Sd. Sweat et al., Androgen receptor expression in prostatic intraepithelial neoplasia and cancer, J UROL, 161(4), 1999, pp. 1229-1232

Authors: Sweat, SD Pacelli, A Bergstralh, EJ Slezak, JM Cheng, L Bostwick, DG
Citation: Sd. Sweat et al., Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery, J UROL, 161(4), 1999, pp. 1233-1237

Authors: Amling, CL Lerner, SE Martin, SK Slezak, JM Blute, ML Zincke, H
Citation: Cl. Amling et al., Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer, J UROL, 161(3), 1999, pp. 857-862
Risultati: 1-11 |